Development of a lentiviral vector system to study the role of the Andes virus glycoproteins

Virus Research

Volumn 153, Issue 1, 2010, Pages 29-35

  Cifuentes Muñoz, Nicolás ^a,b   Darlix, Jean Luc ^c   Tischler, Nicole D ^a,d  

^a Fundacion Ciencia para la Vida   (Chile)

^b UNIVERSIDAD ANDRÉS BELLO   (Chile)

^c CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

^d UNIVERSIDAD SAN SEBASTIÁN   (Chile)

Author keywords

Bunyavirus; Glycoprotein function; Inhibition; Pseudotyped particle

Indexed keywords

CHOLESTEROL; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; MONOCLONAL ANTIBODY; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ANDES VIRUS; ANIMAL CELL; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; FLOW CYTOMETRY; HANTAVIRUS; HELA CELL; HUMAN; HUMAN CELL; LIPID RAFT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REPORTER GENE; SIMIAN IMMUNODEFICIENCY VIRUS; VERO CELL; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS INFECTIVITY;

ANDES VIRUS; HANTAVIRUS; ORTHOBUNYAVIRUS; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 77956225481     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2010.07.001     Document Type: Article

References (77)

1. Arikawa J., Takashima I., Hashimoto N. Cell fusion by haemorrhagic fever with renal syndrome (HFRS) viruses and its application for titration of virus infectivity and neutralizing antibody. Arch. Virol. 1985, 86(3-4):303-313.
2. Cockrell A.S., Kafri T. Gene delivery by lentivirus vectors. Mol. Biotechnol. 2007, 36(3):184-204.
3. Cronin J., Zhang X.Y., Reiser J. Altering the tropism of lentiviral vectors through pseudotyping. Curr. Gene Ther. 2005, 5(4):387-398.
4. Choi Y., Kwon Y.C., Kim S.I., Park J.M., Lee K.H., Ahn B.Y. A hantavirus causing hemorrhagic fever with renal syndrome requires gC1qR/p32 for efficient cell binding and infection. Virology 2008, 381(2):178-183.
5. Deyde V.M., Rizvanov A.A., Chase J., Otteson E.W., St Jeor S.C. Interactions and trafficking of Andes and Sin Nombre Hantavirus glycoproteins G1 and G2. Virology 2005, 331(2):307-315.
6. Dissen G.A., Lomniczi A., Neff T.L., Hobbs T.R., Kohama S.G., Kroenke C.D., Galimi F., Ojeda S.R. In vivo manipulation of gene expression in non-human primates using lentiviral vectors as delivery vehicles. Methods 2009, 49(1):70-77.
7. Elliott R.M. Molecular biology of the Bunyaviridae. J. Gen. Virol. 1990, 71(Pt 3):501-522.
8. Flint M., Logvinoff C., Rice C.M., McKeating J.A. Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins. J. Virol. 2004, 78(13):6875-6882.
9. Foster L.J., De Hoog C.L., Mann M. Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc. Natl. Acad. Sci. U.S.A. 2003, 100(10):5813-5818.
10. Frecha C., Costa C., Negre D., Gauthier E., Russell S.J., Cosset F.L., Verhoeyen E. Stable transduction of quiescent T cells without induction of cycle progression by a novel lentiviral vector pseudotyped with measles virus glycoproteins. Blood 2008, 112(13):4843-4852.
11. Frecha C., Szecsi J., Cosset F.L., Verhoeyen E. Strategies for targeting lentiviral vectors. Curr. Gene Ther. 2008, 8(6):449-460.
12. Garbutt M., Liebscher R., Wahl-Jensen V., Jones S., Moller P., Wagner R., Volchkov V., Klenk H.D., Feldmann H., Stroher U. Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses. J. Virol. 2004, 78(10):5458-5465.
13. Gavrilovskaya I.N., Shepley M., Shaw R., Ginsberg M.H., Mackow E.R. beta3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc. Natl. Acad. Sci. U.S.A. 1998, 95(12):7074-7079.
14. Godoy P., Marsac D., Stefas E., Ferrer P., Tischler N.D., Pino K., Ramdohr P., Vial P., Valenzuela P.D., Ferres M., Veas F., Lopez-Lastra M. Andes virus antigens are shed in urine of patients with acute hantavirus cardiopulmonary syndrome. J. Virol. 2009, 83(10):5046-5055.
15. Goldsmith C.S., Elliott L.H., Peters C.J., Zaki S.R. Ultrastructural characteristics of Sin Nombre virus, causative agent of hantavirus pulmonary syndrome. Arch. Virol. 1995, 140(12):2107-2122.
16. Goldstein J.L., Anderson R.G., Brown M.S. Coated pits, coated vesicles, and receptor-mediated endocytosis. Nature 1979, 279(5715):679-685.
17. Hailstones D., Sleer L.S., Parton R.G., Stanley K.K. Regulation of caveolin and caveolae by cholesterol in MDCK cells. J. Lipid Res. 1998, 39(2):369-379.
18. Heiniger H.J., Kandutsch A.A., Chen H.W. Depletion of L-cell sterol depresses endocytosis. Nature 1976, 263(5577):515-517.
19. Hepojoki J., Strandin T., Vaheri A., Lankinen H. Interactions and oligomerization of hantavirus glycoproteins. J. Virol. 2009, 84(1):227-242.
20. Himathongkham S., Luciw P.A. Restriction of HIV-1 (subtype B) replication at the entry step in rhesus macaque cells. Virology 1996, 219(2):485-488.
21. Hofmann W., Schubert D., LaBonte J., Munson L., Gibson S., Scammell J., Ferrigno P., Sodroski J. Species-specific, postentry barriers to primate immunodeficiency virus infection. J. Virol. 1999, 73(12):10020-10028.
22. Hooper J.W., Larsen T., Custer D.M., Schmaljohn C.S. A lethal disease model for hantavirus pulmonary syndrome. Virology 2001, 289(1):6-14.
23. Ivanchenko S., Godinez W.J., Lampe M., Krausslich H.G., Eils R., Rohr K., Brauchle C., Muller B., Lamb D.C. Dynamics of HIV-1 assembly and release. PLoS Pathog. 2009, 5(11):e1000652.
24. Jantti J., Hilden P., Ronka H., Makiranta V., Keranen S., Kuismanen E. Immunocytochemical analysis of Uukuniemi virus budding compartments: role of the intermediate compartment and the Golgi stack in virus maturation. J. Virol. 1997, 71(2):1162-1172.
25. Jin M., Park J., Lee S., Park B., Shin J., Song K.J., Ahn T.I., Hwang S.Y., Ahn B.Y., Ahn K. Hantaan virus enters cells by clathrin-dependent receptor-mediated endocytosis. Virology 2002, 294(1):60-69.
26. Jouvenet N., Bieniasz P.D., Simon S.M. Imaging the biogenesis of individual HIV-1 virions in live cells. Nature 2008, 454(7201):236-240.
27. Kikkert M., Van Lent J., Storms M., Bodegom P., Kormelink R., Goldbach R. Tomato spotted wilt virus particle morphogenesis in plant cells. J. Virol. 1999, 73(3):2288-2297.
28. Kohler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975, 256(5517):495-497.
29. Krautkramer E., Zeier M. Hantavirus causing hemorrhagic fever with renal syndrome enters from the apical surface and requires decay-accelerating factor (DAF/CD55). J. Virol. 2008, 82(9):4257-4264.
30. Larson R.A., Dai D., Hosack V.T., Tan Y., Bolken T.C., Hruby D.E., Amberg S.M. Identification of a broad-spectrum arenavirus entry inhibitor. J. Virol. 2008, 82(21):10768-10775.
31. Lee B.H., Yoshimatsu K., Araki K., Okumura M., Nakamura I., Arikawa J. A pseudotype vesicular stomatitis virus containing Hantaan virus envelope glycoproteins G1 and G2 as an alternative to hantavirus vaccine in mice. Vaccine 2006, 24(15):2928-2934.
32. Lober C., Anheier B., Lindow S., Klenk H.D., Feldmann H. The Hantaan virus glycoprotein precursor is cleaved at the conserved pentapeptide WAASA. Virology 2001, 289(2):224-229.
33. Lopez N., Padula P., Rossi C., Lazaro M.E., Franze-Fernandez M.T. Genetic identification of a new hantavirus causing severe pulmonary syndrome in Argentina. Virology 1996, 220(1):223-226.
34. Lundkvist A., Scholander C., Niklasson B. Anti-idiotypic antibodies against Puumala virus glycoprotein-specific monoclonal antibodies inhibit virus infection in cell cultures. Arch. Virol. 1993, 132(3-4):255-265.
35. Ma M., Kersten D.B., Kamrud K.I., Wool-Lewis R.J., Schmaljohn C., Gonzalez-Scarano F. Murine leukemia virus pseudotypes of La Crosse and Hantaan Bunyaviruses: a system for analysis of cell tropism. Virus Res. 1999, 64(1):23-32.
36. Mangeot P.E., Duperrier K., Negre D., Boson B., Rigal D., Cosset F.L., Darlix J.L. High levels of transduction of human dendritic cells with optimized SIV vectors. Mol. Ther. 2002, 5(3):283-290.
37. Mangeot P.E., Negre D., Dubois B., Winter A.J., Leissner P., Mehtali M., Kaiserlian D., Cosset F.L., Darlix J.L. Development of minimal lentivirus vectors derived from simian immunodeficiency virus (SIVmac251) and their use for gene transfer into human dendritic cells. J. Virol. 2000, 74(18):8307-8315.
38. Marsh M., Helenius A. Virus entry: open sesame. Cell 2006, 124(4):729-740.
39. McCaughey C., Shi X., Elliot R.M., Wyatt D.E., O'Neill H.J., Coyle P.V. Low pH-induced cytopathic effect - a survey of seven hantavirus strains. J. Virol. Methods 1999, 81(1-2):193-197.
40. Metzger H. Transmembrane signaling: the joy of aggregation. J. Immunol. 1992, 149(5):1477-1487.
41. Mou D.L., Wang Y.P., Huang C.X., Li G.Y., Pan L., Yang W.S., Bai X.F. Cellular entry of Hantaan virus A9 strain: specific interactions with beta3 integrins and a novel 70kDa protein. Biochem. Biophys. Res. Commun. 2006, 339(2):611-617.
42. Naldini L. Medicine. A comeback for gene therapy. Science 2009, 326(5954):805-806.
43. Negre D., Mangeot P.E., Duisit G., Blanchard S., Vidalain P.O., Leissner P., Winter A.J., Rabourdin-Combe C., Mehtali M., Moullier P., Darlix J.L., Cosset F.L. Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells. Gene Ther. 2000, 7(19):1613-1623.
44. Nguyen D.H., Hildreth J.E. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J. Virol. 2000, 74(7):3264-3272.
45. Nuzum E.O., Rossi C.A., Stephenson E.H., LeDuc J.W. Aerosol transmission of Hantaan and related viruses to laboratory rats. Am. J. Trop. Med. Hyg. 1988, 38(3):636-640.
46. Ogino M., Ebihara H., Lee B.H., Araki K., Lundkvist A., Kawaoka Y., Yoshimatsu K., Arikawa J. Use of vesicular stomatitis virus pseudotypes bearing hantaan or seoul virus envelope proteins in a rapid and safe neutralization test. Clin. Diagn. Lab. Immunol. 2003, 10(1):154-160.
47. Ogino M., Yoshimatsu K., Ebihara H., Araki K., Lee B.H., Okumura M., Arikawa J. Cell fusion activities of Hantaan virus envelope glycoproteins. J. Virol. 2004, 78(19):10776-10782.
48. Padula P.J., Edelstein A., Miguel S.D., Lopez N.M., Rossi C.M., Rabinovich R.D. Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus. Virology 1998, 241(2):323-330.
49. Plassmeyer M.L., Soldan S.S., Stachelek K.M., Martin-Garcia J., Gonzalez-Scarano F. California serogroup Gc (G1) glycoprotein is the principal determinant of pH-dependent cell fusion and entry. Virology 2005, 338(1):121-132.
50. Plassmeyer M.L., Soldan S.S., Stachelek K.M., Roth S.M., Martin-Garcia J., Gonzalez-Scarano F. Mutagenesis of the La Crosse Virus glycoprotein supports a role for Gc (1066-1087) as the fusion peptide. Virology 2007, 358(2):273-282.
51. Ray N., Whidby J., Stewart S., Hooper J.W., Bertolotti-Ciarlet A. Study of Andes virus entry and neutralization using a pseudovirion system. J. Virol. Methods. 2010, 163(2):416-423.
52. Rodal S.K., Skretting G., Garred O., Vilhardt F., van Deurs B., Sandvig K. Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol. Biol. Cell 1999, 10(4):961-974.
53. Rothberg K.G., Ying Y.S., Kamen B.A., Anderson R.G. Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate. J. Cell Biol. 1990, 111(6 Pt 2):2931-2938.
54. Ruo S.L., Sanchez A., Elliott L.H., Brammer L.S., McCormick J.B., Fisher-Hoch S.P. Monoclonal antibodies to three strains of hantaviruses: Hantaan, R22, and Puumala. Arch. Virol 1991, 119(1-2):1-11.
55. Salanueva I.J., Novoa R.R., Cabezas P., Lopez-Iglesias C., Carrascosa J.L., Elliott R.M., Risco C. Polymorphism and structural maturation of bunyamwera virus in Golgi and post-Golgi compartments. J. Virol. 2003, 77(2):1368-1381.
56. Sastry L., Xu Y., Cooper R., Pollok K., Cornetta K. Evaluation of plasmid DNA removal from lentiviral vectors by benzonase treatment. Hum. Gene Ther. 2004, 15(2):221-226.
57. Satake M., Luftig R.B. Comparative immunofluorescence of murine leukemia virus-derived membrane-associated antigens. Virology 1983, 124(2):259-273.
58. Schnell M.J., Buonocore L., Kretzschmar E., Johnson E., Rose J.K. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proc. Natl. Acad. Sci. U.S.A. 1996, 93(21):11359-11365.
59. Shi X., Elliott R.M. Golgi localization of Hantaan virus glycoproteins requires coexpression of G1 and G2. Virology 2002, 300(1):31-38.
60. Shi X., Goli J., Clark G., Brauburger K., Elliott R.M. Functional analysis of the Bunyamwera orthobunyavirus Gc glycoprotein. J. Gen. Virol. 2009, 90(Pt 10):2483-2492.
61. Simon M., Johansson C., Mirazimi A. Crimean-Congo hemorrhagic fever virus entry and replication is clathrin-, pH- and cholesterol-dependent. J. Gen. Virol. 2009, 90(Pt 1):210-215.
62. Simons K., Ehehalt R. Cholesterol, lipid rafts, and disease. J. Clin. Invest. 2002, 110(5):597-603.
63. Simons K., Ikonen E. Functional rafts in cell membranes. Nature 1997, 387(6633):569-572.
64. Simons K., Toomre D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 2000, 1(1):31-39.
65. Smart E.J., Anderson R.G. Alterations in membrane cholesterol that affect structure and function of caveolae. Methods Enzymol 2002, 353:131-139.
66. Smit J.M., Bittman R., Wilschut J. Low-pH-dependent fusion of Sindbis virus with receptor-free cholesterol- and sphingolipid-containing liposomes. J. Virol. 1999, 73(10):8476-8484.
67. Soneoka Y., Cannon P.M., Ramsdale E.E., Griffiths J.C., Romano G., Kingsman S.M., Kingsman A.J. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 1995, 23(4):628-633.
68. Spiropoulou C.F., Goldsmith C.S., Shoemaker T.R., Peters C.J., Compans R.W. Sin Nombre virus glycoprotein trafficking. Virology 2003, 308(1):48-63.
69. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427(6977):848-853.
70. Suomalainen M., Garoff H. Incorporation of homologous and heterologous proteins into the envelope of Moloney murine leukemia virus. J. Virol. 1994, 68(8):4879-4889.
71. Takada A., Robison C., Goto H., Sanchez A., Murti K.G., Whitt M.A., Kawaoka Y. A system for functional analysis of Ebola virus glycoprotein. Proc. Natl. Acad. Sci. U.S.A. 1997, 94(26):14764-14769.
72. Tischler N.D., Fernandez J., Muller I., Martinez R., Galeno H., Villagra E., Mora J., Ramirez E., Rosemblatt M., Valenzuela P.D. Complete sequence of the genome of the human isolate of Andes virus CHI-7913: comparative sequence and protein structure analysis. Biol. Res. 2003, 36(2):201-210.
73. Tischler N.D., Galeno H., Rosemblatt M., Valenzuela P.D. Human and rodent humoral immune responses to Andes virus structural proteins. Virology 2005, 334(2):319-326.
74. Tischler N.D., Gonzalez A., Perez-Acle T., Rosemblatt M., Valenzuela P.D. Hantavirus Gc glycoprotein: evidence for a class II fusion protein. J. Gen. Virol. 2005, 86(Pt 11):2937-2947.
75. Trono D. Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene Ther. 2000, 7(1):20-23.
76. von Haller P.D., Donohoe S., Goodlett D.R., Aebersold R., Watts J.D. Mass spectrometric characterization of proteins extracted from Jurkat T cell detergent-resistant membrane domains. Proteomics 2001, 1(8):1010-1021.
77. Waarts B.L., Bittman R., Wilschut J. Sphingolipid and cholesterol dependence of alphavirus membrane fusion. Lack of correlation with lipid raft formation in target liposomes. J. Biol. Chem. 2002, 277(41):38141-38147.